Cardiology Journal Articles

 
 
  • ICH After Thrombolysis in Stroke Patients Using SSRIs Is the risk of post-thrombolysis ICH increased in patients who were taking SSRIs prior to experiencing an acute ischemic stroke? How might outcomes be impacted?
  • Is a DASH of Salt All We Need? In this commentary, the authors explore some of the intriguing questions raised by the landmark DASH-sodium trial, as well as possible pathophysiologic mechanisms of sodium-induced hypertension.
  • Anatomical, Electrical Remodeling With Incomplete LAA Ligation What are the anatomical, electrical, and clinical impacts of incomplete Lariat left atrial appendage ligation?
  • Multivessel PCI on Its 40th Anniversary: A Match for CABG? Has contemporary PCI narrowed the gap sufficiently to declare it the preferred revascularization method for most patients with complex multi-vessel disease?
  • Current State of Public Reporting Dr. Hadley Wilson of the ACC outlines the College's current efforts to enhance public reporting while ensuring high-quality clinical data, and underscores its commitment to transparency.
  • Early Versus Delayed Statin Therapy in Acute Ischemic Stroke Might immediate initiation of statin therapy enhance neuroprotection or promote stroke recovery after acute ischemic stroke?
  • CT or Functional Stress Testing for the Prediction of Risk Should we choose CT angiography over CAC scoring for the prediction of cardiovascular events? And what about functional stress testing? This commentary suggests a "one size does not fit all" approach.
  • Frailty Syndrome: A Problem in the Management of Arrhythmias How prevalent is frailty in everyday practice and how does it influence the clinical management of arrhythmias?
  • Clopidogrel After 1 Month in Stabilized ACS Patients A new study investigates switching from prasugrel or ticagrelor to clopidogrel vs. continuing either drug after a PCI for ACS. Will the results change clinical practice?
  • The Age of Diagnostic Coronary Angiography Is Over Newer, non-invasive alternatives to coronary angiography are widely available. Is diagnostic angiography still necessary?
  • Cardiovascular Complications of Cancer Therapy Cancer therapy can have serious cardiovascular complications. Learn about the cardiac effects of commonly used chemotherapies and how best to prevent and manage them in this overview.
  • Thrombolysis in Postoperative Stroke Recent surgery is generally considered a contraindication to intravenous thrombolysis. Can IVT be performed safely in patients with postoperative stroke?
  • Acute Stress and Abnormal Left Atrial Electrophysiology What might be the mechanism by which acute mental stress triggers atrial fibrillation?
  • Rebranding HF: Who Would Be Branded With Failure? In this commentary, the author wonders if the "heart failure" label, which connotes defeat and stigma, is hindering effective care.
  • The Heart in Rheumatic, Autoimmune and Inflammatory Diseases This new book is likely to become a standard reference for cardiologists and rheumatologists caring for patients with cardiovascular manifestations of inflammatory diseases, according to the reviewer.
  • Nuclear Cardiology: Correct Use of Protocols and Tracers How can we improve the safety of nuclear cardiology studies without compromising results? This review examines different radiopharmaceuticals and study protocols and their impact on safety.
  • A Test in Context: D-Dimer What is the role of D-dimer in diagnosis and management of venous thromboembolism? This review examines the mechanisms involved in its production and its use as a marker in VTE and other conditions.
  • Designing an Optimal Screening Program for Unknown AF At which age should screening for atrial fibrillation be initiated? This study used computer simulations to determine an optimal age and evaluate the value of repeated screenings.
  • Stem Cell Therapy: Translational Hurdles to New Frontiers This brief commentary summarizes recent developments in the use of stem cells and regenerative therapy in cardiovascular diseases.
  • A New Strategy for High-Sensitivity Troponin in the ED Is it time to extend our use of hs-cTn in the acute setting beyond just ruling out acute illness? In this commentary, the author explores the utility of hs-cTn as a marker of subclinical pathology.